Toxicologic and teratologic studies with 1-(3,5-bis-trifluoromethyl)phenyl)-4-methyl-thiosemicarbazide (CIBA 2696Go).
D000014:Abnormalities, Drug-Induced; D000284:Administration, Oral; D000818:Animals; D000831:Animals, Newborn; D001219:Aspartate Aminotransferases / Q000097:blood; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000633:toxicity*; D004285:Dogs; D005260:Female; D005461:Fluorine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000633:toxicity; D005865:Gestational Age; D006400:Hematocrit; D007928:Lethal Dose 50; D051379:Mice; D010060:Ovulation / Q000187:drug effects; D011247:Pregnancy; D051381:Rats; D012663:Semicarbazides / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000633:toxicity*; D013440:Sulfides / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000633:toxicity
D003276:Contraceptives, Oral; D012663:Semicarbazides; D013440:Sulfides; D005461:Fluorine; D001219:Aspartate Aminotransferases